Android app Apple app link

JPMorgan and UBS Raise PT for Teva Pharmaceutical (TEVA)

By Yahoo! Finance   |   1 month ago
JPMorgan and UBS Raise PT for Teva Pharmaceutical (TEVA)

JPMorgan and UBS raised Teva Pharmaceutical Industries Ltd.'s price target to $26, expecting positive Q3 earnings. Teva focuses on biopharmaceuticals and generics, showing growth potential. Consider other AI stocks for higher returns.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.